Atlas Trials

Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis

Clinical trial NCT00117104 · COMPLETED

Trial details

NCT number
NCT00117104
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
End Stage Renal Disease

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.